Koyfin Home > Directory > Health Care > Adamas Pharma > Capital Expenditures

Adamas Pharma Capital Expenditures Chart (ADMS)

Adamas Pharma annual/quarterly Capital Expenditures from 2012 to 2019.
  • Adamas Pharma Capital Expenditures for the quarter ending December 12, 2019 was $0m a 0.00% increase of 0m year over year
  • Adamas Pharma Capital Expenditures for the last 12 months ending June 06, 2020 was $0m a 0.00% decrease of -1m year over year
  • Adamas Pharma Annual Capital Expenditures for 2019 was $0m a -5,811.11% increase of 1m from 2018
  • Adamas Pharma Annual Capital Expenditures for 2018 was $-1m a -18.23% increase of 0m from 2017
  • Adamas Pharma Annual Capital Expenditures for 2017 was $-1m a -29.09% increase of 0m from 2016
Other Cash Flow Metrics:
  • Adamas Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-24m a -5.06% increase of 1m year over year
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Capital Expenditures Data

12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$1m
09/2018$-1m
06/2018$0m
03/2018$-1m
12/2017$0m
09/2017$0m

Annual ADMS Capital Expenditures Data

2019$0m
2018$-1m
2017$-1m
2016$-2m
2015$-1m
2014$-1m
2013$0m
2012$0m
2011$0m